Health Advances Blog

Reflections on Healthcare & Life Sciences Innovation

Skip to content
Menu
  • Home
  • About
  • COVID-19 Impact
  • Visit Our Website
  • Contact Us

Category: Market Access & Health Policy

India Biosimilars
  • by healthadvances
  • Posted on July 21, 2021

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Read More
  • by healthadvances
  • Posted on April 8, 2020April 13, 2020

How COVID-19 May Redirect US Healthcare Reform Priorities

Read More
  • by healthadvances
  • Posted on October 29, 2019April 13, 2020

Health Advances Presentation at AMCP Nexus: Costs of Mandating Blister Packaging for Opioids

Read More
  • by healthadvances
  • Posted on April 16, 2019April 13, 2020

Better Market Access in China – Government Improves Pricing and Reimbursement Environment

Read More
  • by healthadvances
  • Posted on April 7, 2019April 13, 2020

Keytruda, a case study for the improved regulatory environment in China

Read More
  • by healthadvances
  • Posted on March 27, 2019April 13, 2020

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Read More
  • by healthadvances
  • Posted on November 9, 2018April 13, 2020

Health Advances Presentation at ISPOR: An Initial Analysis of the Cost-Based Pricing Revisions in Japan

Read More
  • by healthadvances
  • Posted on November 9, 2018April 13, 2020

Health Advances Presentation at ISPOR: Findings from the First Five Years of the NICE HST Program for Ultra Rare Conditions

Read More
  • by healthadvances
  • Posted on August 23, 2018April 13, 2020

Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies

Read More
  • by healthadvances
  • Posted on May 3, 2018April 15, 2020

Patient Advocacy Groups as a Strategy for Orphan Drug Access in the UK

Read More
  • by healthadvances
  • Posted on January 16, 2018April 15, 2020

PART 2: 2018 Wildcards – Healthcare Regulation and Models of Care

Read More
  • by healthadvances
  • Posted on June 25, 2015April 15, 2020

Drug Pricing & Reimbursement at the Boston CMO Network

Read More
  • by healthadvances
  • Posted on June 22, 2015April 15, 2020

Pricing Orphan and Specialty Drugs-Insights from the World Orphan Drug Congress & ISPOR

Read More

Stay Connected

Enter your email address to subscribe to Health Advances blog and receive notifications of new posts by email.

We use WordPress as our blog publishing platform. By entering your email address, you acknowledge that the information you provide will be transferred to WordPress for processing in accordance with their Privacy Policy and Terms.

Topics of Interest

  • Asia/APAC Markets
  • BioPharma
  • COVID-19
  • Diagnostics and Life Science Tools
  • European Markets
  • Health IT and Digital Health
  • Investors
  • Launch Excellence
  • Market Access & Health Policy
  • MedTech
  • Other

Search Our Blog

Follow Us on Social Media

  • View healthadvances’s profile on Facebook
  • View @healthadvances’s profile on Twitter
  • LinkedIn

Recent Tweets

My Tweets
This website uses cookies. You may choose to continue browsing with cookies or leave the site.

Health Advances Privacy Policy
Create a website or blog at WordPress.com
 

Loading Comments...